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ABSTRACT
Objectives: The aims were to assess the contribution of arg-gly-asp (RGD) mediated cell integrin–
matrix bonds to interstitial hydraulic resistance and to fenestrated endothelial permeability in joints.
Joint fluid is generated by filtration from fenestrated capillaries and drains through a fibronectin-
rich synovial intercellular matrix. The role of parenchymal cell–matrix bonding in determining tissue
hydraulic resistance is unknown.
Methods: The knee cavity of anesthetized rabbits was infused with saline or the competitive hexapep-
tide blocker GRGDTP, with or without added osmotic stress (600 mosm saline). Intra-articular pressure
Pj, net trans-synovial drainage rate Q˙s, and the permeation of Evans blue-labeled albumin (EVA) from
plasma into the joint cavity were measured.
Results: GRGDTP increased the hydraulic conductance of the synovial drainage pathway, dQ˙s/dPj,
by 71% (p = .02, paired t test, n = 6 animals). Synovial plasma EVA clearance (control 7.1 ± 0.8 µL
h−1, mean ± SEM, n = 15) was unaffected by GRGDTP (7.0 ± 2.3 µL h−1, n = 6) or hyperosmolarity
(4.9 ± 1.5 µL h−1, n = 8) but was increased by GRGDTP and hyperosmolarity together (15.9 ±
4.8 µL h−1, n = 5) (p = .01, ANOVA). Changes in dPj/dt evoked by GRGDTP plus hyperosmolarity,
but neither alone, demonstrated increased microvascular filtration into the joint cavity (p < .001,
ANOVA), as did changes in fluid absorption from the infusion system at fixed Pj.
Conclusions: RGD-mediated bonds between the parenchymal cells and interstitial polymers reduce
the interstitial hydraulic conductance by 42%. This helps to retain the lubricating fluid inside a
joint cavity. RGD-mediated bonds also support the macromolecular barrier function of fenestrated
endothelium, but in vivo this is evident only in stressed endothelium (cf. in vitro).
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INTRODUCTION
Synovium, the sheet of tissue surrounding a joint cav-
ity, is responsible for both the formation and the
drainage of the lubricating fluid in the cavity. Its
accessibility makes it a useful model for studying
interstitial permeability, as well as being function-
ally important. Synovium is composed of a discon-
tinuous layer of fibroblast-related synoviocytes and
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macrophages with broad interstitial spaces and a net-
work of fenestrated capillaries just below the surface.
In extended joints the pressure in the cavity is low
and the capillaries slowly filter fluid into the cavity.
Flexion raises the intraarticular pressure and drives
fluid out of the cavity through the synovial intersti-
tial matrix into the periarticular lymphatic system,
maintaining volume homeostasis. The interstitial hy-
draulic resistance is thus a crucially important cou-
pling coefficient in joint fluid turnover, as is also the
case in many other tissues.
Interstitial hydraulic resistance is the result of hy-
draulic drag by the interstitial matrix biopolymers
(49). In synovium these include fibronectin, vit-
ronectin, laminin, tenascin, entactin, fibromodulin,
heparan, and chondroitin sulfate proteoglycans,
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hyaluronan, and collagen types I, III, IV, V, and VI
(27,33). To generate hydraulic drag, however, the
biopolymers must be anchored, and the role of an-
chorage has received relatively little investigation.
Anchorage could arise in principle from extracellular
polymer–polymer interactions, as in cartilage, and/or
from cellular–extracellular linkages. The contribu-
tion of the latter to interstitial hydraulic resistance
has never, to our knowledge, been studied. Synovium
may, in principle, utilize both types of anchorage. For
example, fibronectin is abundant in synovium (29)
and binds to extracellular fibrin, collagen types I, III,
V, and VI (15,55) and heparan sulfate proteoglycan
(54), as well as to the synovial lining cell integrins
α5β1 and αVβ1 (16,42).
The integrins are a family of >20 transmembrane
α−β heterodimers that are tethered to the cytoskele-
ton via talin, vinculin, and α-actinin at focal adhe-
sions. Both the synovial parenchymal cells and the
endothelium express the integrins α5β1 (binds fi-
bronectin) (1,9,16,30); αVβ3 (binds vitronectin, fi-
bronectin, tenascin, fibrinogen) (43,52); α6β1 (binds
laminin) (16,36), and α1β1 (binds collagen and
laminin) (35). Synovial parenchymal cells also ex-
press αVβ1 (binds vitronectin, fibronectin) (15,33).
Integrins not only anchor matrix polymers but also
mediate outside-to-in signaling via integrin-linked
kinases, which can transduce matrix stress into in-
tracellular signaling cascades (12,31,45,48,51). In-
tegrins also mediate inside-to-out effects, such as the
regulation of interstitial fluid pressure by fibroblasts
through α2β1-collagen bonds in rat skin and tracheal
mucosa (2,41) and endothelial barrier regulation (see
below).
A specific arginine–glycine–aspartate (RGD) con-
sensus sequence in the extracellular biopolymer
ligand mediates around half the known integrin–
ligand interactions, including α5β1-fibronectin and
αVβ1-vitronectin (15,31,46). The assembly of solu-
ble fibronectin into matrix fibrils involves both α5β1-
RGD and αVβ3-RGD interactions (56). The RGD
consensus sequence is exposed in fibronectin, vit-
ronectin, fibrinogen, von Willebrand factor, laminin,
entactin, tenascin, and some forms of collagen. The
RGD sequence is recognized by the integrins α5β1,
α8β1, αVβ1, αVβ3/5/6/8, and in some cases α2β1
(46).
When cells bound to glycoproteins are exposed to a
suitably flanked, synthetic RGD-sequence oligopep-
tide, such as GRGDTP (Gly-Arg-Gly-Asp-Thr-Pro)
or GRGDSP (S, serine), the competition between
the oligopeptide and endogenous glycoprotein for
α5β1 and αVβ1 binding sites leads to cell detach-
ment (11,13,46). GRGDTP also inhibits cell attach-
ment to perlecan, fibrinogen, and von Willebrand fac-
tor (4,30) and in some cell lines α1β1/α2β1-collagen
binding, but not laminin or collagen type IV binding
(11,46). These effects are quite rapid. RGD-sequence
peptide causes cell detachment and rounding in vitro
within 2 h (5). In endothelium in situ, RGD evokes
changes that are detectable within 5 min, persist
up to 3 h, are maximal at ≥10−4 M peptide, and
are reversed by washout (57). The above observa-
tions show that integrin–RGD links are dynamic and
accessible to competitive block by exogenous RGD-
sequence peptide.
Many studies in vitro have shown that RGD–integrin
interactions support the barrier function of contin-
uous endothelium from macrovessels grown on an
artificial base such as fibronectin (3). The treat-
ment of such monolayers with RGD-sequence peptide
or α5β1 antibody increases the macromolecular per-
meability (7,21), raises the hydraulic conductance
3-fold, reduces endothelial adhesion and causes in-
tercellular gap formation (40). The integrin expres-
sion and permeability of macrovessel endothelium
cultured in vitro on a synthetic substrate is not nec-
essarily a safe guide, however, to the properties of
intact microvessels in vivo. Much less is known about
the functional importance of RGD-mediated bonds
in intact microvessels, and nothing is known in rela-
tion to fenestrated endothelium. In isolated porcine
coronary venules, RGD-sequence peptide increased
the albumin permeability by up to 4.5-fold within
minutes (57). By contrast, in the only studies on mi-
crovessels in situ, namely frog mesenteric venules,
neither GRGDTP alone nor hyperosmolar saline
alone affected the endothelial hydraulic conductance
(17,18). When 10-min exposure to GRGDTP was
supplemented by osmotic stress, however, the en-
dothelial conductance increased by ∼27%. Thus, in
the continuous endothelium of amphibia in vivo it was
necessary to increase the stress on weakened/residual
integrin–matrix bonds to reveal RGD bond function-
ality. In view of the partially conflicting literature,
there is a need to investigate further the role of RGD
in intact microvessels in vivo. Moreover, the role of
RGD in fenestrated endothelium, as opposed to con-
tinuous endothelium, has never previously been in-
vestigated.
The present study therefore tests the hypotheses that
(1) RGD-mediated bonds between interstitial ma-
trix and parenchymal cell integrins contribute to in-
terstitial hydraulic resistance; and (2) fenestrated
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endothelial barrier function in vivo depends partly on
RGD-mediated bonds. These hypotheses were tested
by infusing rabbit knee joints with GRGDTP in iso-
tonic or hyperosmotic saline and measuring their ef-
fects on 3 parameters: plasma-to-joint protein per-
meation (a measure of endothelial barrier function),
changes in joint fluid pressure with time (an index
of capillary filtration rate), and the trans-synovial
drainage rate versus pressure relation (a measure of
synovial interstitial matrix conductance). Synthetic
RGD rather than a specific anti-integrin or anti-
matrix antibody was chosen as the blocking agent
for several reasons, including the “broad-spectrum’’
blockade of multiple types of RGD-dependent bonds
by RGD (cf. limited, selective block by specific anti-
bodies), the extremely high cost of sufficient antibody
for rabbits in vivo, and a commercial lack of specifi-
cally anti-rabbit antibodies.
METHODS
Overview
The study used an established rabbit knee model.
After an iv injection of Evans blue-labeled albumin
(EVA) into the plasma compartment, the joint cav-
ity was cannulated to record intraarticular pressure
(Pj). A small bolus of isotonic/hypertonic saline ±
GRGDTP was injected intraarticularly and the Pj
response was recorded for 30 min. A second can-
nula was then introduced and connected to a raised
fluid reservoir and in-line drop counter. The reser-
voir height controlled Pj, and this was increased every
15 min to chart the relation between Pj and net trans-
synovial flow Q˙S. Intraarticular fluid was aspirated
every 15 min to quantify EVA permeation across the
blood–joint barrier. The key measured parameters
were thus dPj/dt, which reflects the imbalance be-
tween interstitial drainage from the cavity and cap-
illary filtration into it; ClEVA, the clearance of Evans
blue-albumin from synovial plasma into joint cav-
ity; and dQ˙S/dPj, the hydraulic conductance of the
synovial lining. The experiment was usually repeated
on the contralateral joint with an appropriate control
solution.
Experimental Preparation: Determination of dPj/dt
and dQ˙S/dPj
New Zealand white rabbits of 2.5–3 kg were anes-
thetized with 30 mg kg−1 sodium pentobarbitone
plus 500 mg kg−1 urethane iv and tracheostomized.
Anesthesia was maintained at sufficient depth to
abolish the corneal blink reflex using intravenous
15 mg sodium pentobarbitone plus 250 mg ure-
thane every 30 min. Procedures conformed to United
Kingdom animal legislation and the animals were
killed humanely by an overdose of iv sodium pen-
tobarbitone at the end of the experiment.
The intraarticular infusion system, pressure and flow
transducers, and chart recorder were as described
in (6) and (38). Initially a single cannula was in-
serted into the joint cavity to deliver a bolus of 200-
to 300-µL test solution. The subsequent decay/rise
in Pj was followed for 30 min. The pressure decay
provides information about the balance between mi-
crovascular filtration into the joint cavity and trans-
synovial drainage out of it through the parallel inter-
stitial pathway (37). The reason is as follows. In a
closed joint the fluid pressure Pj at constant joint an-
gle depends on intraarticular fluid volume and elas-
tance (19). Changes in net trans-synovial flow alter
the intraarticular volume and therefore Pj. The net
trans-synovial flow in vivo is the difference between
the capillary filtration into the cavity and the spa-
tially separate trans-synovial drainage out of it (23).
A similar study was repeated post mortem, because
integrin–matrix influences on interstitial fluid pres-
sure are best demonstrated after capillary perfusion
has ceased (41).
After 30 min the intraarticular fluid was aspirated for
EVA analysis (see below) and a second intraarticular
cannula was inserted and connected to an infusion
reservoir. The height of the reservoir clamped Pj at
any desired level. Flow from the infusion reservoir
into the joint cavity, Q˙in, was recorded by a pho-
toelectric drop counter. Due to the very high cost of
synthetic hexapeptide, only the terminal 10 mL of the
infusion system was filled with the test solution. An
inverted-U air gap separated the test solution from
drop counter fluid, namely 0.1% v/v chlorhexidine
(Hibitane, ICI, Macclesfield, UK). The latter gener-
ated 6-µL droplets. A step elevation of the infusion
reservoir caused a transient inrush of test fluid into
the joint as the cavity expanded, then Pj stabilized
and the rate of absorption of infusate by the joint
reached a steady state within 15 min, as described
previously (38).
Flows were measured at the end of each 15-min pe-
riod (Q˙in) at successive pressures of ∼2.5, 5.0, and
7.5 cm H2O (below yield pressure) to estimate the
physiological conductance of the joint lining, then
at ∼12, 18, and 24 cm H2O (corresponding to taut
effusions) to chart the raised conductances above
the yield pressure of the synovial lining (22). Net
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trans-synovial drainage rate Q˙s was calculated from
Q˙in at the end of each period by subtracting a small
correction for the viscoelastic creep of the cavity walls
as described in (6). When interpreting changes in Q˙s
it is important to bear in mind that the measured pa-
rameter equals a net flow, comprising the interstitial
drainage rate out of the cavity minus the capillary
filtration rate into it (23,25). The latter becomes sig-
nificant relative to the drainage rate at low intraar-
ticular pressures and during osmotic infusions into
the joint cavity.
Macromolecular Permeation and Synovial Plasma
Clearance, ClEVA
A 10-mL injection of Evans blue-labeled albumin
(EVA) was given through the ear vein at the start
of the experiment. The solution comprised 10 mM
Evans blue bound to 120 mg mL−1 bovine serum al-
bumin in Ringer solution (dye binding >99%) (26).
Venous blood was sampled at 30 min and at the end,
∼270 min. At 30 min, and thereafter at the end of
each 15-min trans-synovial flow determination, the
intraarticular fluid was aspirated and weighed. The
EVA contents of the aspirated fluid and centrifuged
venous plasma were analyzed by spectrophotometry
at 600 nm (Du-62, Beckman Instruments, Fullerton,
CA, USA). From the results the EVA flux from syn-
ovial plasma into the joint cavity, dm/dt, was calcu-
lated as described in (38), then divided by plasma
concentration Cp to give the synovial plasma clear-
ance, ClEVA. Cp at a given time point was calculated
by linear interpolation between the plasma concen-
trations at 30 and 270 min.
Intraarticular Half-Life of Rapidly Diffusible Solutes
The intraarticular concentration of a small, rapidly
diffusible solute such as GRGDTP (601.6 Da) de-
cays fairly rapidly in vivo due to clearance by the
microcirculation. For solutes of size 370–582 Da the
measured intraarticular half-life is 14–24 min (37).
For this reason, and also for the purpose of EVA sam-
pling, the joint was aspirated as completely as possi-
ble every 15 min and refilled with fresh solution. In
this way the fall in intraarticular concentration was
limited to ≤12 the nominal concentration before the
next top-up.
Materials
The specificity of the hexapeptide H2N-Gly-Arg-Gly-
Asp-Thr-Pro-COOH (GRGDTP) is well documented
(11,46). The GRGDTP (601.6 Da) was obtained
from Novabiochem (Nottingham, UK), Calbiochem
(Nottingham, UK) and Advanced Biotechnology
Centre (ABC, Faculty of Medicine, Imperial College,
London, UK). The infused concentration was 3 mM
in an isotonic physiological salt solution (see be-
low) for the first 2 pressure-flow studies and 10 mM
(6 mg mL−1) for all other studies. A concentra-
tion above the literature values for cell-binding in-
hibition and endothelial permeability elevation (1–
2 mg mL−1) (11,17,40) was selected to allow for
the unavoidable decay in intraarticular concentra-
tion over 15 min in vivo. The number of exper-
iments was limited by the high cost of synthetic
hexapeptide and the large quantities required for
work on a rabbit joint in vivo. For the same rea-
son non-RGD hexapeptide was not used as a con-
trol in the present study; however, studies by oth-
ers on cultured cells (7) and isolated venules (57)
confirm that non-RGD hexapeptide is biologically
inactive. The physiological salt solution was a ster-
ile, pyrogen-free mammalian Ringer solution com-
prising 147 mM Na+, 4 mM K+, 2 mM Ca2+, and
153 mM Cl− (Baxter Healthcare, Thetford, Norfolk,
UK) of osmolarity 306 mosm/L. Osmotic stress was
induced by the addition of 147 mmol NaCl/L to
the Ringer solution to raise its total osmolarity to
600 mosm/L.
Statistical Methods
The effect of treatment on ClEVA–time, Pj–time, and
Pj–Q˙s relations was assessed by 2-way analysis of
variance (ANOVA). Changes in slope or intercept
were assessed by linear regression analysis, paired
t test, and analysis of covariance (ANCOVA) using
GraphPad Prism (San Diego, California). To com-
pare flows at identical pressures (since Pj varied a
little between experiments), flows were interpolated
to standard pressures by linear interpolation between
the two bounding measurements. Other results were
compared using 1-way ANOVA with Neuman–Keuls
post hoc multiple comparison test as appropriate,
taking p ≤ .05 as a significant difference. Means
and slopes are followed by their standard errors
throughout.
RESULTS
We describe first the changes in transendothelial al-
bumin permeation, then changes in capillary filtra-
tion rate as revealed by changes in dPj/dt, and finally
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changes in interstitial matrix conductance as revealed
by changes in dQ˙s/dPj.
Permeation of EVA from Plasma into the Joint Cavity
Samples of intraarticular fluid from joints infused
with isotonic Ringer solution (15 joints) or 10 mM
GRGDTP alone (6 joints) or hyperosmolar Ringer
solution (8 joints) were almost colorless. By con-
trast, samples aspirated from joints infused with
10 mM GRGDTP in hyperosmolar Ringer solution
(n = 5 joints) were visibly blue from 30–45 min
onward, showing that GRGDTP and hyperosmolar-
ity acted synergistically to cause a relatively rapid,
sustained increase in transendothelial macromolec-
ular permeation (Figure 1A). Two-way ANOVA of
the ClEVA–time results confirmed that treatment with
GRGDTP plus hyperosmolarity significantly raised
plasma EVA clearance compared to hyperosmolar-
ity alone (p < .002), and that time did not sig-
nificantly influence the clearance value (p = .81),
i.e., the increase in EVA permeation was sustained
over ∼2 h. By contrast, treatment with GRGDTP
in isotonic Ringer solution did not significantly in-
crease ClEVA compared with the isotonic control joints
(p = .87, 2-way ANOVA) (Figure 1B).
The mean ClEVA in joints treated with GRGDTP plus
hyperosmolarity was 15.9 ± 4.8 µL h−1 (n = 5
joints) (Figure 1C). This was 3.2 times higher than
the mean ClEVA in joints infused with hyperosmo-
lar Ringer solution, namely 4.9 ± 1.5 µL h−1 (n = 8
joints) (p = .01, 1-way ANOVA). Five of the 8 hyper-
osmolar experiments were paired with GRGDTP plus
hyperosmolarity in the opposite joint; the ClEVA was
greater on the GRGDTP-treated side in all 5 cases.
The ClEVA values in joints receiving hyperosmolar
Ringer solution, isotonic Ringer solution (7.1 ± 0.8
µL h−1, n = 15 joints), and GRGDTP in isotonic
Ringer (7.0 ± 2.3 µL h−1, n = 6 joints) were not
significantly different from each other (p > .05,
Newman–Keuls multiple comparison test). The ef-
fect of GRGDTP in hyperosmolar Ringer was signifi-
cantly greater than the effect of GRGDTP in isotonic
Ringer (p < .05, Neuman–Keuls test). Due to the
high cost of synthetic peptide and the large amounts
required, it was not feasible to evaluate the dose–
response relations.
The fractional albumin extraction from synovial mi-
crovessels can be calculated as ClEVA divided by the
synovial plasma flow, which we previously estimated
to be 45–90 µL min−1 (38). The low extraction in
control joints, 0.13–0.26%, indicated that the basal
microvascular permeability to plasma protein was
low despite the presence of fenestrations, in keep-
ing with an earlier determination of the albumin re-
flection coefficient (20). The extraction increased to
0.29–0.59% in joints treated with GRGDTP plus hy-
perosmolarity, but this is still an order of magnitude
less than the extraction following F-actin disruption,
namely 3–6% (38).
Effect of RGD and Hyperosmolarity
on the Intraarticular Pressure–Time Relation
We have shown previously that increases in synovial
capillary filtration rate manifest themselves by a re-
duction or even reversal of the decay of intraarticular
pressure Pj with time following a small intraarticu-
lar bolus injection, because increased filtration into
the cavity offsets drainage out of it (37); see Meth-
ods. A 200- to 300-µL bolus of isotonic Ringer so-
lution, or GRGDTP (10 mM) in Ringer solution, was
injected to raise Pj to ∼1.5–2.0 cm H2O and gen-
erate a net trans-synovial outflow. Pj decayed with
time because the trans-synovial drainage rate ex-
ceeded capillary filtration into the cavity (Figure 2A).
The decay in Pj, and hence net volume loss, was
only marginally less in joints that received GRGDTP
(n = 7 joints) than in those receiving plain Ringer
solution (n = 7). The difference was 0.33 ± 0.01 cm
H2O over 30 min (p = .08, 2-way ANOVA). The
results indicated that GRGDTP in isotonic fluid re-
duced the net trans-synovial outflow in vivo only
slightly and with marginal statistical significance.
Experiments to compare Ringer and GRGDTP Pj–
time curves were also carried out immediately af-
ter arresting the heart by an intravenous pentobar-
bitone overdose. The aims were (1) to test whether
the marginal GRGDTP-induced reduction in net out-
flow in vivo still occurred after capillary perfusion had
ceased, and (2) to test whether RGD-mediated cell–
matrix bonds influence extravascular fluid pressure
(by opposing the gel swelling pressure; see Introduc-
tion and reference 41). The intraarticular bolus was
reduced to 100–150 µL so that the Pj–time relation
started close to atmospheric pressure. With both test
solutions Pj fell to just below atmospheric pressure
within minutes and stabilized at a slightly subatmo-
spheric pressure beyond 5–10 min. The mean fall
in Pj in 3 GRGDTP-treated joints, −0.73 cm H2O,
was not significantly different from that in the Ringer
controls, −0.89 cm H2O (p = .23, 2-way ANOVA).
The Pj-versus-time regression slopes beyond 5 min
were not significantly different from zero, either for
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Figure 1. Permeation of Evans blue-labeled plasma albumin into the joint cavity expressed as plasma clearance (ClEVA)
i.e., flux/plasma concentration (mean ± SEM). (A) Time course of clearance in 8 joints infused with hyperosmolar
Ringer solution (600 mosm) and 5 joints infused with GRGDTP peptide in hyperosmolar Ringer plus (p < .002, 2-way
ANOVA). (B) Time course of clearance in joints infused with isotonic Ringer solution (n = 15) or GRGDTP in isotonic
Ringer solution (n = 6) (p = .81, 2-way ANOVA). (C ) Time-averaged ClEVA for the 4 treatments: isotonic Ringer
solution (n = 15 joints), GRGDTP in isotonic Ringer solution (n = 6 joints), 600 mosm Ringer solution (n = 8 joints),
and GRGDTP in 600 mosm Ringer solution (n = 5 joints). ClEVA for last group was significantly higher than other three
(∗∗ p = .01, 1-way ANOVA). Differences among the other three groups were not significant (p > .05, Neuman–Keuls
multiple comparison test).
RGD peptide and synovial permeability
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Figure 2. Effect of GRGDTP ± hyperosmolarity on in-
traarticular pressure decay (an index of net trans-synovial
flow) following a small bolus injection (200–300 µL) into
the joint cavity (mean ± SEM). (A) GRGDTP in isotonic
Ringer solution in vivo (n = 7) attenuated the Pj decay
marginally relative to Ringer solution (n = 7) (p = .08,
2-way ANOVA). (B) GRGDTP in hyperosmolar Ringer so-
lution in vivo (n = 4) greatly attenuated the decay of Pj
when compared with hyperosmolar Ringer solution in the
contralateral joint (n = 4) (p < .001, 2-way ANOVA)
or GRGDTP in isotonic Ringer solution in unpaired joints
(A).
Ringer solution (−0.0023 ± 0.0019 cm H2O min−1)
or for GRGDTP (0.0107 ± 0.0055 cm H2O min−1).
Disruption of the synoviocyte actin cytoskeleton by
cytochalasin likewise has no effect on Pj or on syn-
ovial interstitial fluid pressure postmortem (37).
As in the EVA clearance experiments, GRGDTP plus
hyperosmotic stress caused more striking changes
(Figure 2B). In control joints that received a bolus
of 600 mosm Ringer solution, Pj decayed from an
initial 1.43 ± 0.17 cm H2O to almost atmospheric
pressure in 30 min (n = 4 joints). In the paired, con-
tralateral knees, which received a bolus of GRGDTP
in 600 mosm Ringer (n = 4), the decay in Pj with
time was greatly attenuated, indeed almost halted
(p = .0005, 2-way ANOVA). The mean Pj fell by
less than 0.3 cm H2O, from 1.71 ± 0.68 cm H2O at
time zero to 1.43 ± 0.56 cm H2O at 30 min. More-
over, in one of the experiments the pressure ceased
to decay at 13 min, reversed direction at 20 min,
and thereafter increased slowly with time. We showed
previously that the reduction/reversal of dPj/dt is
caused by increased synovial microvascular filtration
into the joint cavity, which counterbalances the con-
comitant fluid drainage (37). The decay of dPj/dt in
joints receiving GRGDTP plus hyperosmolar saline,
−0.009 ± 0.003 cm H2O min−1 over 10–30 min,
was 27% of that in the joints receiving hyperosmo-
lar saline alone, −0.033 ± 0.001 cm H2O min−1
(p = .0002, ANCOVA). The large change in dPj/dt,
along with the substantial increase in ClEVA, indicates
that GRGDTP increases the flux of water and plasma
protein across the endothelial barrier during osmotic
stress (see Discussion).
Hyperosmolarity per se reduced the pressure decay
only slightly, though significantly, as shown by com-
parison of the isotonic Ringer curves (n = 7, mean
initial Pj = 1.88 ± 0.30 cm H2O) and 600 mosm
Ringer curves (unpaired, n = 7, mean initial Pj =
1.93 ± 0.52 cm H2O). Pj after the hyperosmolar bo-
lus decayed less rapidly and remained on average
0.69 ± 0.04 cm H2O higher than the isotonic val-
ues over 30 min (p = .008, 2-way ANOVA). Sim-
ilarly, 2 previous studies showed that hyperosmolar
intraarticular solutions attenuate Pj decay in vivo and
that this effect depends on synovial microvascular
filtration, since it is abolished by circulatory arrest
(25,47).
Effect of GRGDTP on the Trans-Synovial
Flow–Pressure Relation
In the following two-cannula experiments Pj was
“clamped’’ at various, raised levels by continuous
intraarticular infusion and the corresponding net
trans-synovial drainage rate Q˙s was measured; see
Methods. Under these conditions the Q˙s–Pj relation
is dominated by the conductance of the interstitial
drainage pathway, because most of the fluid drain-
ing out of the cavity bypasses the synovial capillar-
ies and enters the loose areolar subsynovium where
the initial lymphatic plexus is located (22,23). The
Q˙s–Pj relation for isotonic saline across synovium is
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Figure 3. Effect of GRGDTP in isotonic Ringer solu-
tion (•) on relation between net trans-synovial drainage
rate and joint fluid pressure, compared with relation for
Ringer solution in contralateral joint of same animal (◦).
Mean ± SEM, 6 animals; some error bars fall inside sym-
bol. GRGDTP increased the steepness of the relation i.e.,
the synovial lining hydraulic conductance (linear regres-
sion analysis; see Results).
conventionally approximated by 2 straight lines, with
a steepening above ∼8–10 cm H2O (yield pressure)
caused by increased interstitial hydraulic conductiv-
ity and stretch (22,23). The slope increased signifi-
cantly above yield pressure for all the infusates in this
study (p < .0001, ANCOVA) (Figures 3–5).
Figure 3 shows the trans-synovial outflow Q˙s as a
function of Pj for 6 joints infused with GRGDTP in
isotonic Ringer solution and 6 contralateral joints
of the same animals infused with isotonic Ringer
solution. GRGDTP increased the slope and shifted
the intercept of the relation. The Pj intercept (pres-
sure for zero net trans-synovial flow) was raised by
1.7 cm H2O (p = .02, paired t test, n = 6). At the
lowest pressure, 2.5 cm H2O, GRGDTP reduced the
net outflow from 3.5 ± 1.0 µL min−1 (control) to
0.1 ± 1.1 µL min−1 (p = .05, paired t test). These
observations support the inference from Figure 2A
that GRGDTP treatment reduces the net trans-
synovial outflow at low pressures.
At all pressures >5 cm H2O, GRGDTP treatment
raised the net trans-synovial outflow (p = .04, 2-
way ANOVA), because it increased the slope of the
relation dQ˙s/dPj in all 6 pairs of joints. GRGDTP
increased the regression slope dQ˙s/dPj below yield
Figure 4. Comparison of effect of hyperosmotic Ringer
solution (, mean ± SEM, n = 7 joints) and isotonic Ringer
solution (◦, n = 9, unpaired studies) on net trans-synovial
outflow. Hyperosmolarity reduced net outflow significantly
(p = .02, 2-way ANOVA) due to a change of intercept,
but had no significant effect on slope. For linear regression
parameters see Results.
Figure 5. Effect of GRGDTP in hyperosmolar Ringer so-
lution ( , n = 4 joints, mean ± SEM) on relation between
net trans-synovial outflow and joint fluid pressure, com-
pared with hyperosmolar Ringer solution in contralateral
joints of same animal (, n = 4). GRGDTP in hyper-
osmolar solution significantly increased the pressure in-
tercept but the change in slope was not significant; see
Results.
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pressure by 71%, from a mean of 1.50 ± 0.41 µL
min−1 cm H2O−1 (Ringer solution, n = 6 joints)
to 2.56 ± 0.39 µL min−1 cm H2O−1 (GRGDTP,
n = 6 joints) (p = .02, paired t test). The substantial
effect of GRGDTP in isotonic Ringer on synovial lin-
ing hydraulic conductance dQ˙s/dPj contrasted with
its lack of effect on transendothelial plasma EVA
clearance (Figure 1). Above yield pressure the in-
crease in slope dQ˙s/dPj evoked by GRGDTP did not
reach statistical significance; the slope was 5.77 ±
1.67 µL min−1 cm H2O−1 for the GRGDTP-infused
joints and 3.90 ± 0.46 µL min−1 cm H2O−1for the
Ringer-infused joints (n = 6 joints; p = .36, paired
t test).
Effect of Hyperosmolarity on the Trans-Synovial
Flow–Pressure Relation
Infusions of 600 mosm Ringer solution were carried
out as controls for the GRGDTP–osmotic stress ex-
periments (next section). Figure 4 compares the Pj–
Q˙s relations in isotonic (n = 9) and hyperosmolar-
infused joints (n = 7, unpaired). Hyperosmolarity
reduced the net trans-synovial outflows throughout
the pressure range (p = .02, 2-way ANOVA), due
to an almost parallel rightward shift of the Pj–Q˙s re-
lation. Hyperosmolarity shifted the y-axis intercept
from −0.46 ± 3.07 µL min−1 for the isotonic control
(x intercept 0.23 cm H2O) to −4.50 ± 2.38 µL
min−1 (x intercept 2.43 cm H2O) (p = .003,
ANCOVA). Parallel shifts of this nature are charac-
teristic of osmotic forces acting on a semipermeable
membrane, i.e., capillary wall; see Discussion.
Hyperosmolarity had no significant effect on slope
dQ˙s/dPj. The slopes below yield pressure averaged
1.58 ± 0.29 µL min−1 cm H2O−1 for hyperosmo-
lar infusions (n = 7 joints) and 1.72 ± 0.34 µL
min−1 cm H2O−1 for isotonic infusions (n = 9 joints)
(p = .76, unpaired t test). The slopes above yield
pressure averaged 4.14 ± 0.53 µL min−1 cm H2O−1
for hyperosmolar infusions (n = 7 joints) and 3.90 ±
0.46 µL min−1 cm H2O−1 for isotonic infusions
(p = .74, unpaired t test). Hyperosmolarity per se
did not, therefore, change the hydraulic conductance
of the synovial lining significantly.
Effect of GRGDTP Plus Osmotic Stress
on Trans-Synovial Flow–Pressure Relation
Figure 5 summarizes the results of 4 paired experi-
ments in which GRGDTP in 600 mosm Ringer solu-
tion was infused into one joint and 600 mosm Ringer
solution into the contralateral joint of the same ani-
mal. The addition of GRGDTP reduced the net trans-
synovial outflows slightly but significantly over the
whole pressure range (p = .003, 2-way ANOVA). The
reduction was brought about by a downward shift
in the y intercept in every case, from a mean of
−1.8 ± 2.9 µL min−1 for the hyperosmolar controls
to −9.3 ± 3.5 µL min−1 for GRGDTP plus hyper-
osmolarity (p = .01, paired t test, n = 4 animals).
The reduced net outflows at supraatmospheric pres-
sures and the negative shift in the y-intercept (i.e.,
increased trans-synovial flow directed into the joint
cavity at atmospheric pressure) are attributed to in-
creased microvascular filtration (see Discussion).
The 41% increase in the mean slope below yield pres-
sure, from 1.18 ± 0.39 µL min−1 cm H2O−1 for the
hyperosmolar controls to 1.66 ± 0.44 µL min−1 cm
H2O−1 for GRGDTP in hyperosmolar Ringer solu-
tion, was not statistically significant (p = .5, paired
t test, n = 4 animals). Slope analysis using pooled
raw data confirmed this (GRGDTP in hyperosmolar
Ringer 1.96 ± 0.45 µL min−1 cm H2O−1, hyperos-
molar controls 1.56 ± 0.43 µL min−1 cm H2O−1;
p = .58, ANCOVA: n = 16). There was likewise no
significant difference in slope above yield pressure,
where mean dQ˙s/dPj was 3.32 ± 0.53 µL min−1 cm
H2O−1 for GRGDTP in hyperosmolar solution and
3.94 ± 0.31 µL min−1 cm H2O−1 for the paired hy-
perosmolar controls (p = .39, paired t test: n = 4
animals).
DISCUSSION
The principal positive findings were that in the ab-
sence of osmotic stress, GRGDTP increased the trans-
synovial drainage rate per unit intraarticular pressure
(interstitial matrix conductance) but had no effect
on plasma albumin permeation into the joint cav-
ity (endothelial permeation). Under conditions of os-
motic stress, GRGDTP increased albumin clearance
from synovial plasma into the joint cavity, almost ar-
rested the usual intraarticular pressure decay after
a small bolus injection, and reduced the net trans-
synovial drainage rate over a wide range of intraar-
ticular pressure. We focus first on RGD-induced en-
dothelial changes, then on RGD-induced interstitial
matrix changes.
Contribution of RGD Sequence to Fenestrated
Endothelial Barrier Function
The fenestrated endothelium of synovial capillaries
is the major barrier to plasma protein entry into the
RGD peptide and synovial permeability
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joint cavity (20,38). The breakdown of this barrier
in arthritis leads to the formation of large, protein-
rich arthritic effusions (53). A partial breakdown of
the barrier is inferred from the 3-fold increase in
ClEVA in response to GRGDTP plus osmotic stress
(Figure 1A). An alternative interpretation, namely
that the increased ClEVA was caused by increased
convective transport evoked by the interstitial hy-
perosmolarity, was excluded by the control obser-
vation that 600 mosm Ringer solution did not raise
ClEVA (Figure 1C). Since GRGDTP in isotonic so-
lutions had no effect on ClEVA (Figure 1B), it ap-
pears that both a reduction in endothelial tether-
ing and an increase in endothelial cytoskeletal stress
may be necessary for the moderate permeability
increase.
Increases in endothelial permeability to macro-
molecules are commonly accompanied by increases
in hydraulic permeability and filtration rate (10,14,
32,44). Increased microvascular filtration was evi-
dent from the near abolition of Pj decay by GRGDTP
plus osmotic stress (Figure 2). In these experiments
external fluid was not infused continuously, so Pj de-
cayed because joint fluid outflow through the par-
allel interstitial drainage pathway exceeded the cap-
illary filtration rate into the joint cavity (23). The
decay rate is reduced or reversed when increased
capillary filtration rate counterbalances or exceeds
the cavity drainage rate. Similarly, moderate disrup-
tion of the synovial endothelial barrier by 25 µM
cytochalasin D attenuates Pj decay, while gross dis-
ruption by >50 µM cytochalasin D causes a slow
rise in Pj (37). The vascular origin of the atten-
uation/reversal of dPj/dt was confirmed by circu-
latory arrest, which abolishes such responses (37).
Increased microvascular filtration was also evident
from the rightward shift of the trans-synovial flow–
pressure relation (Figure 5), as discussed later.
The effect of GRGDTP in isotonic solution on Pj de-
cay was slight and of marginal statistical significance
(Figure 2A), and was not accompanied by any in-
crease in macromolecular permeability (Figure 1B).
Since the attenuation of Pj decay was not evident af-
ter circulatory arrest, it may (if significant at all) be
due to a slight rise in capillary filtration rate elicited
by the osmotic pressure of 10 mM GRGDTP, although
the effective osmotic pressure of the latter will be
slight due to the low fenestral reflection coefficient for
crystalloids (20). A hyperosmolar solution of chon-
droitin sulfate causes a more marked, circulation-
dependent attenuation of Pj decay (47), but chon-
droitin sulfate (58,800 Da) is a larger molecule than
GRGDTP with, presumably, a higher endothelial os-
motic reflection coefficient.
Comparison with Previous Studies
of RGD–Endothelium Interaction
The present results are the first, to the best of our
knowledge, to reveal a role for RGD-mediated bonds
in fenestrated, as opposed to continuous, endothe-
lium. Although the RGD-mediated bonds clearly in-
fluence the fenestrated endothelium permeability,
this is apparent only when the endothelium is sub-
jected to a large osmotic stress. Even then the effect
is a relatively modest 3-fold increase, in contrast to
the 25-fold increase in albumin clearance that fol-
lows endothelial F-actin disruption by cytochalasin D
(38). These findings parallel those of an earlier study
of continuous endothelium in situ by Kajimura and
Curry (17). They found that RGD–peptide in hyper-
osmolar saline, but neither alone, increased the hy-
draulic conductance of amphibian venular endothe-
lium, though only moderately. The relatively small
effects reported here and in (17), on intact microves-
sels in situ in both cases, contrast with the effect on
cultured endothelium in vitro, where RGD-sequence
peptide greatly increases the macromolecular and hy-
draulic permeability in the absence of additional os-
motic stress (7,21,40). The difference could be due to
the use of purified artificial substrata in endothelial
cultures and/or changes in integrin expression by cul-
tured endothelium. Functional differences between
endothelium in vitro and in vivo are also indicated by
the fact that hyperosmolarity per se raises the per-
meability of cultured pulmonary artery endothelium
(50) but neither frog mesenteric microvessels in vivo
(17,18) nor rabbit synovial microvessels in vivo (Fig-
ure 1). These results reinforce the need for great cau-
tion when applying results obtained in culture to liv-
ing vessels in situ.
More puzzling is the contrast between the results on
microvessels in situ (17,18, and here) and results on
isolated coronary venules, where RGD-sequence pep-
tide without added osmotic stress raised the macro-
molecular permeability up to 4.5-fold (57). The
difference in responsiveness to isotonic RGD might
be due to increased endothelial fragility in isolated
venule segments, due to the unavoidable dissection
and the 1 h of preperfusion. Alternatively, the dif-
ference might be related to tissue/species differences
in integrin and matrix expression. It seems clear,
however, from the present results and those in (17),
that there is a redundancy of endothelial attachment
RGD peptide and synovial permeability
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bonds in both continuous and fenestrated microves-
sels in situ, so that disruption of RGD-mediated
bonds alone does not affect permeability unless an
additional stress is imposed, and even then the per-
meability increase is only moderate.
Mechanisms by Which RGD Sequence Peptide
Influences the Endothelial Barrier
The simplest explanation for the effects of RGD
plus osmotic stress would be that RGD-peptide re-
duces the endothelial adhesion to the basal lamina.
When the reduced tethering is combined with an in-
crease in endothelial tension brought about by hy-
perosmolar cell volume reduction, the endothelial
distortion triggers macromolecule-permeable path-
way formation. The pathway might be intercellu-
lar or transcellular channels (32,44,57), perhaps
related to vesiculo-vacuolar organelles (10). The
RGD-dependent ligands fibronectin and vitronectin
appear to be only minor components of the basal
lamina quantitatively (28), but may be important
because their counterligands, the integrins α5β1 and
αVβ1,3, are concentrated at the margins of the para-
cellular pathway, at least in cultured endothelium
(21). Of the main quantitative constituents of basal
lamina (laminin, type IV collagen, perlecan), only the
perlecan–endothelium bond is partly RGD mediated
(30). The lack of effect of isotonic GRGDTP is at-
tributed to the known endothelial expression of non-
RGD-dependent integrins, such as α2β1, which bind
to the major basal lamina constituents, collagen and
laminin. Such bonds presumably provide sufficient
endothelial tethering to maintain barrier integrity in
low-stressed RGD-blocked endothelium in situ.
The above mechanical hypothesis may well prove
overly simplistic, because Kajimura and Curry (17)
showed that the effect of GRGDTP plus osmotic stress
is abolished by 60–100 mM K+. The high [K+] de-
polarizes the cell, which reduces the electrochemical
force driving extracellular Ca2+ entry. Increased en-
dothelial [Ca2+]i activates the cGMP-protein kinase
G cascade, leading to a dissociation of junctional pro-
teins from the cytoskeleton and increased permeabil-
ity (14,34). Intracellular Ca2+ concentration rises in
renal epithelial cells exposed to RGD peptide-coated
beads (51). Moreover, increased integrin stress trig-
gers Ca2+ influx into fibroblasts (12), causes tyro-
sine phosphorylation of cytoskeletally anchored pro-
teins (48), and alters integrin-related kinase activity
(8,45). Synovial endothelial barrier integrity is heav-
ily dependent on the actin cytoskeleton (38), which
is linked to intercellular junctional proteins and to
integrins. Taking the above facts into account, a pos-
sible working hypothesis is that changes in integrin
stress induced by RGD and hyperosmolarity trigger
changes in kinase activity and a rise in endothelial
[Ca2+]i which leads via kinase cascades to endothe-
lial barrier modulation.
Interstitial Matrix–Parenchymal Cell Bonds
as Determinants of Interstitial Resistance
GRGDTP in isotonic Ringer solution altered both the
slope and the intercept of the net flow–pressure rela-
tion. The small but significant increase in the pressure
intercept at zero net trans-synovial flow (Figure 3),
along with the marginal reduction in Pj decay in
Figure 2A and its abolition by circulatory arrest, may
be due to a small effective osmotic pressure exerted by
interstitial GRGDTP on the abluminal face of the fen-
estrated capillaries, of the order ≤0.9% of the van’t
Hoff osmotic pressure. A consequent rise in capillary
filtration rate will significantly reduce the measured
net flow Q˙s at low Pj, because the rate of fluid ab-
sorption from the infusion reservoir (Q˙s) equals the
total fluid drainage through the interstitial pathway
minus the fluid input into the joint cavity by the syn-
ovial capillary bed. Similar osmotic effects have been
demonstrated with other hyperosmolar solutions in
joints (25,47).
Of greater physiological interest is the 71% increase
in slope dQ˙s/dPj below yield pressure evoked by
GRGDTP in isotonic saline. Since endothelial per-
meability was unchanged (Figure 1), and the net
trans-synovial outflow at raised Pj passes mainly
through the synovial interstitial pathway (22,23), we
conclude that GRGDTP increases the hydraulic con-
ductance of the trans-synovial interstitial pathway.
In other words, intact RGD-mediated bonds lower
the hydraulic permeability of the normal joint lining
0.58-fold, and are thus important in the retention
of the lubricating synovial fluid inside a joint cav-
ity. Nevertheless, matrix-degrading enzymes produce
much bigger, ≥400%, increases in synovial conduc-
tance (49), so we must also conclude that non-RGD
bonds have an even greater role.
Above yield pressure, the slope is governed by the rate
at which synovial conductance increases with pres-
sure, rather than conductance per se (22). The con-
ductance increases due to tissue stretch and increased
hydration (24,39).
As reviewed in the Introduction, synovial parenchy-
mal cells express the RGD-binding integrins α5β1
RGD peptide and synovial permeability
474 A Poli et al.
(binds fibronectin) and αVβ1 (binds vitronectin). The
increase in dQ˙s/dPj evoked by exogenous hexapep-
tide indicates that disruption of native RGD–integrin
bonds increases the freedom of movement of the
matrix components, promoting matrix disorgani-
zation and increased hydraulic permeability. Bond
disruption presumably creates new/larger water-
conducting channels, perhaps at the cell margins.
Synoviocytes also express non-RGD-dependent in-
tegrins such as α1β1 (binds collagen), so GRGDTP
probably causes only partial, selective matrix detach-
ment. This may explain why the conductance in-
crease was modest (71%) compared with the much
bigger, ≥400%, increases produced by matrix de-
grading enzymes (49).
Hyperosmolarity alone did not affect dQ˙s/dPj
(Figure 4), so we conclude that osmotic stress of
the parenchymal cells does not raise the intersti-
tial conductance. Similarly, although interstitial hy-
perosmolarity reduces cell volume in rat abdominal
muscle, it has little effect on interstitial hydration
and, by implication, conductance (58). The latter
group also reported that net trans-peritoneal fluid
drainage is reduced by intraperitoneal hypertonicity,
because an osmosis-induced microvascular filtration
partly offset the hydraulic flow. This parallels the
present findings that hyperosmolarity attenuates Pj
decay and depresses the net trans-synovial drainage–
pressure relation (Figure 4). These findings indicate
that an osmotic force can partly offset the hydraulic
gradient. The similar depression of net trans-synovial
outflow by intraarticular hyperosmolar chondroitin
sulfate solution is known to be brought about by os-
motically increased capillary filtration, because it is
abolished by circulatory arrest (47). The magnitude
of the intercept displacement in Figure 4 is small due
to three factors: the low crystalloid osmotic reflec-
tion coefficient of fenestrated endothelium (20), local
perifenestral dilution of the osmotic agent by capil-
lary filtrate (23), and the large, parallel leak through
synovial interstitium into subsynovium (23).
The effect of GRGDTP in hyperosmotic Ringer so-
lution on the pressure–flow relation (Figure 5) was
partly as expected from the above discussion and
partly at odds with expectation. The increase in pres-
sure intercept at zero net trans-synovial flow was as
expected, because the endothelial permeability in-
creased (Figure 1A) and capillary filtration rate in-
creased (Figure 2B). Puzzlingly, however, the slope
dQ˙s/dPj increased by only 41% relative to the hyper-
osmolar controls (difference not significant), whereas
GRGDTP in isotonic Ringer solution increased the
slope significantly by 71%. A speculative explana-
tion for the lesser effect of GRGDTP in hyperos-
motic solution might be that osmotic shrinkage of
the synovial cells caused a reorganization of the
matrix biopolymers through non-RGD links, which
partly counteracted the effects of integrin–RGD bond
disruption.
In conclusion, the study showed that (1) RGD-
mediated linkages between the fenestrated endothe-
lium and its substratum are necessary to maintain
the barrier to plasma albumin and fluid under con-
dition of increased mechanical stress, but are not
essential under normal conditions. The latter implies
a considerable redundancy of tethering bond types
in microvessels in situ, in contrast to the findings
of others in vitro (2) RGD-mediated linkages be-
tween parenchymal cells and extracellular biopoly-
mers were shown for the first time to contribute to
the low hydraulic conductance of interstitial matrix.
Maintenance of a low conductance is functionally im-
portant in joints because it retains the lubricating
fluid inside the cavity. The findings should also un-
derpin our understanding of arthritic effusions, in
which increased cytokine levels alter the synovial
integrin expression (35,42,43) and high metallo-
protease levels may expose normally shielded RGD
sequence, e.g., on collagens, and liberate soluble
RGD-containing fragments.
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